UNSPSC 51283306: Levofuraltadone hydrochloride

This classification denotes an antimicrobial solution C13H16N4O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZIA9BC2JJR, chemically known as furaltadone hydrochloride, l-, but more generally known as levofuraltadone hydrochloride, which bears US NIH Compound Identifier 56840909. Most nations schedule levofuraltadone hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, LEVOFURALTADONE HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. SMILES: C1CC(OC1/C=N/N2C[C@@H](OC2=O)CN3CCOCC3)[N+](=O)[O-].CL.

UNSPSC 51283306 Levofuraltadone hydrochloride is a Commodity code, but recent state and local procurement activity shows minimal direct solicitation for this specific pharmaceutical ingredient. The opportunities tagged to this code involve broader medical supply and pharmaceutical procurement—naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and therapeutic pharmacy direct-to-manufacturer programs—rather than levofuraltadone hydrochloride specifically. State and local issuing bodies pursuing pharmaceutical supply contracts span county health departments, municipal fire services, state health and human services agencies, and multistate cooperative purchasing alliances. When pharmaceutical procurement does appear, solicitations typically target generic drugs, emergency-response medications, and OTC supplies rather than specialized veterinary or niche active pharmaceutical ingredients.

Recent activity is concentrated in Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS, response due July 26, 2023) for naloxone and safe drug deactivation systems—1,900 units of naloxone and 800 deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford. The City of Tampa's Purchasing Department solicited medical and first aid supplies (IFB 26P00145, response due March 13, 2026) for the Tampa Fire Department Rescue Division, with an estimated contract amount of $700,000 and a Small Local Business Enterprise set-aside with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, responses due March 26, 2026) to establish contracts for generic pharmaceuticals and OTC products distributed across state and local government facilities, including Oregon participants, requiring products to be market-available by May 15, 2026. The Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The code itself shows limited recent relevance to state and local procurement; businesses evaluating this Commodity should monitor broader pharmaceutical supply and emergency-response medication categories instead.